4 februari 2022: In India kan kanker ernstige sociale en economische gevolgen hebben, meestal resulterend in armoede in het gezin en maatschappelijk onrecht. In dit demografisch jonge land zijn de gerapporteerde leeftijdsgecorrigeerde kankerincidentiecijfers nog vrij laag. Op een bevolking van 1.3 miljard mensen worden elk jaar iets meer dan 1 miljoen nieuwe gevallen van kanker ontdekt. In voor leeftijd gecorrigeerde termen weerspiegelt dit ongeveer een vierde van de incidentie bij mannen en vrouwen in West-Europa. Kanker daarentegen was verantwoordelijk voor naar schatting 600000 tot 700000 dodelijke slachtoffers in India in 2012.
Volgens de Global Burden of Disease Study 2019-analyse van de IHME-studie is het beeld wereldwijd niet bijzonder verschillend. In 2019 overtrof het aantal nieuwe gevallen van kanker de 23 miljoen, tegen 18.7 miljoen in 2010. In 2019 waren er 10 miljoen sterfgevallen door kanker, tegen 8.29 miljoen in 2010. Deze resultaten laten een stijging van respectievelijk 20.9 procent en 26.3 procent zien .
In both developing and developed countries, cancer is a leading cause of morbidity and mortality. The majority of the population in many low- and middle-income nations, including India, does not have access to a well-organized and well-regulated cancer care system. When a person is diagnosed with cancer, they are often forced to spend a lot of money on their own health. Such expenses can push entire families into poverty and, when paired with a lack of what are considered acceptable services, can jeopardize social stability. It can be easily said that cancer treatment in India is still in a nascent stage and huge development is required in this field.
There are two major problems cancer patients and their family members face when someone is diagnosed with cancer. One is, where will they get the best and most appropriate treatment, and two, how much money will be required for treatment? Second is the most important question, as the general population in India is still devoid of health insurance. We at CancerFax addresses both these problems. We help cancer patients find most appropriate and economical cancer treatment in India and abroad. CancerFax is working with more than 100 top cancer hospitals in 10 countries like Dana-Farber, Mayo Clinic, Boston Children’s Hospital, Sheba, Asan, Apollo, BLK, Artemis to name a few.
CAR T-Cell therapy is a breakthrough treatment for some kinds of lymphoma, leukemia and multiple myeloma. CancerFax helps patients enroll for CAR T-celtherapie treatment in the USA, Israel and China. Many patients who had previously relapsed blood tumors had no evidence of cancer after CAR T-Cell therapy. It has also aided in the rehabilitation of patients who have previously failed to respond to most traditional cancer therapies. There are more than 300 ongoing clinical trials in the world’s leading cancer centers on this therapy. CAR T-Cell therapy in India is available as clinical trials now. I hope it will be available for commercial treatment very soon.
